Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Abstract Background Visceral metastases account for 48–67% of metastatic breast cancer (MBC) patients and presage a worse overall survival. Previous study suggested potential effect of nab-paclitaxel on patients with visceral metastases subgroups. This phase II trial was conducted to explore the eff...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
BMC
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/8b66bb85b7d0499482ca3c9ffebd7fdc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|